Chronic Kidney Disease Major Risk Factor for COVID-19 Severity and Mortality, A Scoping Review

Authors

  • Bahzad Einollahi Nephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran Author
  • Luca Cegolon Local Health Unit N. 2 “Marca Trevigiana”, Public Health Department, Treviso, Italy Author
  • Shi Zhao JC School of Public Health and Primary Care, Chinese University of Hong Kong, Hong Kong, China Author
  • Alireza Ghadian Author
  • Mohammad Javanbakht Nephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran Author

Abstract

A growing body of evidence points out at chronic kidney disease (CKD) as a major risk factor for severe COVID-19, increasing also the respective mortality risk. Preventive measures, rapid monitoring organ function and interventions capable of preventing multiorgan failures are of great importance to reduce adverse outcomes in COVID-19 patients with CKD. While efforts are underway to carry out indirect protection interventions and large-scale vaccination to achieve herd immunity in the general population, direct protection of patients with CKD through rapid vaccination trials are necessary since uraemia and immunosuppressive agents could have a negative impact on vaccination responses of CDK patients. More epidemiological data are needed for in-depth understanding of the course and outcome of COVID-19 in CKD patients, supporting clinical decision-making.

 

DOI: 10.52547/ijkd.6797

Downloads

Download data is not yet available.

Downloads

Published

2021-09-09

Issue

Section

BRIEF REVIEW | Kidney Diseases

How to Cite

Chronic Kidney Disease Major Risk Factor for COVID-19 Severity and Mortality, A Scoping Review. (2021). Iranian Journal of Kidney Diseases, 15(5), 323-326. https://ijkd.org/index.php/ijkd/article/view/6797